Oxytocin to Enhance Integrated Treatment for AUD and PTSD
ClinicalTrials.gov · NCT04523922 · Registry updated: 2026-07-27
- Condition / research focus
- PTSD; Alcohol Use Disorder
- Sponsor
- Medical University of South Carolina
- Countries with listed sites
- United States
- Registry dates and results
- Start: 2021-03-29. Completion: 2026-04-13 (may be estimated). No results posted in this registry response.
Products and interventions (3)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
- 40 IU Intranasal Oxytocin (drug) — also listed as: oxytocin
- Placebo (drug) — also listed as: saline
- Concurrent Treatment of PTSD and Substance Use Disorders using Prolonged Exposure (behavioral) — also listed as: COPE
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
- Medical University of South Carolina
Charleston, South Carolina, United States
Site recruitment: Not reported